WO1979000871A1 - A compress for treatment of wounds - Google Patents
A compress for treatment of wounds Download PDFInfo
- Publication number
- WO1979000871A1 WO1979000871A1 PCT/SE1979/000075 SE7900075W WO7900871A1 WO 1979000871 A1 WO1979000871 A1 WO 1979000871A1 SE 7900075 W SE7900075 W SE 7900075W WO 7900871 A1 WO7900871 A1 WO 7900871A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- wound
- compress
- sodium chloride
- wounds
- treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/42—Use of materials characterised by their function or physical properties
- A61L15/44—Medicaments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/10—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing inorganic materials
- A61L2300/102—Metals or metal compounds, e.g. salts such as bicarbonates, carbonates, oxides, zeolites, silicates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
Definitions
- moist sodium chloride compresses are mainlv used at present, i.e. compresses soaked in an isotonic or a hypertonic sodium chloride solution. These moist compresses are placed in the wound and then a common bandage is applied. Sodium chloride solution on wounds prevents crust formations and keeps the wound soft and pliable, so that joints can be bent. Besides the epithelization of the wound bottom is facilitated and the secretion from the wound is absorbed into the compress. A hypertonic sodium chloride solution also has a cleaning effect on non-vital wound tissue by osmotically "bursting" poorly vital cells. This solution to some extent also has an antibacterial effect - at least prevents the growth of several types of bacteria.
- the sodium chloride compress however has the great advantage that the patient never becomes sensibilisized by the treatment. On the contrary to this compresses treated with antibiotics, which are used to a certain extent, causes sensibilization in many cases.
- a new medical dressing Debrisan however has not shown sensibilization and is told to have better absorbation capacity than moist sodium chloride compresses.
- the disadvantages of this preparation however are a very high price and that it is difficult to apply, since the active substance is a dry powder, which easily runs out from the wound.
- a new type of a salt compress is provided, which is prepared by immersing a compress in a solution containing sodium chloride and/or zinc salt(s), after which the compress is dried.
- the salt remains in the compress.
- the salt sodium chloride or zinc salt
- the compresses which are somewhat stiff, are carefully pressed against the wound with a spatula and are fixed with a bandage against the moist wound bottom, at which they soften at the same time as secretion from the wound is absorbed by the compress.
- the wound bottom is in connection herewith cleaned and crust formation is prevented, since the protein in the secretion, which is a basic substance for crust formation, will go into the compress.
- An antibacterial effect is also achieved, since the bacteria will follow the secretion into the compress and there be exerted to a strong osmotic effect from the salt in the compress. Since the dry compress has a good osmotic effect the risk for inflammation in and around the wound is decreased. This leads to pain easing. .
- the dry salt compress has the same effect on the wound as conventional moist sodium chloride compresses.
- moist sodium chloride compresses have several advantages compared to moist sodium chloride compresses, by the fact that the wet handling of these and unnecessary manual work for the nursing staff at the handling of salt solutions in bottles are avoided. Moreover moist sodium chloride compresses have to be changed several (3-6) times a day, while 2 changes normally is sufficient for dry salt compresses .
- Tests have been made in the form of an open study on 15 patients with peripheric wounds of different geneses. Five patients had gangrenous wounds owing to arterial insufficience in a foot or the feet. Three patients had decubitus in the gluteal region. Four patients had wounds on an amputation stump. One patient had a chronically infected wound in the hip area on the left side after a collum fracture and operation. One patient had a chronically infected wound oh the left forearm caused by pressure from a plaster bandage. One patient had a wound from a radiation damage.
- the nursing staff performing the treatment of the wounds of the patients were satisfied with the simplicity of the bandaging of the wounds.
- the patients were pleased with the dry salt compresses, because they usually involved only two changes a day and because the compresses did not stuck in the wounds and causing pain at the changing.
- Cultivation of bacteria in seven cases showed a considerable reduction of the mixed flora of bacteria in the wounds but slight or no effect on staphylo cocci.
- the dry sodium chloride compresses have proved to have an unexpectedly positive effect, i.e. several important advantages and no disadvantages compared to the conventional treatment with moist sodium chloride compresses.
- the compress is delivered in a sterile packing in the usual way.
- zinc salts can be used in the compress.
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19792945420 DE2945420A1 (de) | 1978-04-03 | 1979-03-30 | A compress for treatment of wounds |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE7803697 | 1978-04-03 | ||
SE7803697A SE425350B (sv) | 1978-04-03 | 1978-04-03 | Steril kompress for behandling av vetskande sar innehallande salt i fast form |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1979000871A1 true WO1979000871A1 (en) | 1979-11-01 |
Family
ID=20334470
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/SE1979/000075 WO1979000871A1 (en) | 1978-04-03 | 1979-03-30 | A compress for treatment of wounds |
Country Status (7)
Country | Link |
---|---|
US (1) | US4608044A ( ) |
EP (1) | EP0015933B1 ( ) |
DE (1) | DE2945420C2 ( ) |
ES (1) | ES479183A1 ( ) |
GB (1) | GB2035802B ( ) |
SE (1) | SE425350B ( ) |
WO (1) | WO1979000871A1 ( ) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0153915A2 (en) * | 1984-02-17 | 1985-09-04 | Mölnlycke AB | A dressing and a method for the manufacture thereof |
EP0206692A2 (en) * | 1985-06-14 | 1986-12-30 | Ed. Geistlich Söhne Ag Für Chemische Industrie | Topically administrable pharmaceutical compositions |
EP0608497A1 (en) * | 1992-10-30 | 1994-08-03 | Sparta Surgical Corporation | Hypertonic saline dressing |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4872865A (en) * | 1985-10-09 | 1989-10-10 | Harrington Arthritis Research Center | Hypertonic solution for arthroscopic surgery |
US5340363A (en) * | 1986-03-10 | 1994-08-23 | Molnlycke Ab | Wound dressing |
US4820279A (en) * | 1986-03-31 | 1989-04-11 | Dedo Richard G | Article and method for prepping a patient prior to surgery |
ZA939117B (en) * | 1992-12-04 | 1994-08-05 | Susanna Elizabeth Chalmers | Pharmaceutical product |
DE10017795C2 (de) * | 2000-04-10 | 2002-03-21 | Franz Hubert | Verwendung von mit gesättigter Kochsalzlösung getränkten Tampons, Zellstoffplatten oder Vliesen zur Behandlung von Hämorrhoiden, Krampfadern oder Besenreisern |
US20170216486A1 (en) * | 2016-01-29 | 2017-08-03 | Genadyne Biotechnologies, Inc. | System and Method for Treating a Wound |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE101756C ( ) * | ||||
DE112192C ( ) * |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1504911A (en) * | 1922-04-24 | 1924-08-12 | Firm Gallatin & Cie | Bolus gauze |
US1554027A (en) * | 1924-06-06 | 1925-09-15 | Niederlausitzer Bad Reichenhal | Isotonic solution |
US2430740A (en) * | 1942-08-29 | 1947-11-11 | Arthur E Sharples | Therapeutic dressing |
US2442973A (en) * | 1944-07-12 | 1948-06-08 | Sidney M Edelstein | Treatment of textile material with alkaline cellulose zincate solutions |
US2579367A (en) * | 1950-11-24 | 1951-12-18 | Hynson Westcott & Dunning Inc | Bandage |
US2887112A (en) * | 1957-08-15 | 1959-05-19 | Sanborn Company | Pad for skin preparation for electrocardiography and the like |
US4166108A (en) * | 1977-01-31 | 1979-08-28 | Robert Brown | Styptic composition |
-
1978
- 1978-04-03 SE SE7803697A patent/SE425350B/sv not_active IP Right Cessation
-
1979
- 1979-03-30 WO PCT/SE1979/000075 patent/WO1979000871A1/en unknown
- 1979-03-30 DE DE2945420A patent/DE2945420C2/de not_active Expired
- 1979-03-30 GB GB7940616A patent/GB2035802B/en not_active Expired
- 1979-04-02 ES ES479183A patent/ES479183A1/es not_active Expired
- 1979-11-05 EP EP79900341A patent/EP0015933B1/en not_active Expired
-
1982
- 1982-02-26 US US06/352,515 patent/US4608044A/en not_active Expired - Lifetime
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE101756C ( ) * | ||||
DE112192C ( ) * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0153915A2 (en) * | 1984-02-17 | 1985-09-04 | Mölnlycke AB | A dressing and a method for the manufacture thereof |
US4685907A (en) * | 1984-02-17 | 1987-08-11 | Molnlycke Ab | Dressing and a method for the manufacture thereof |
EP0153915A3 (en) * | 1984-02-17 | 1989-10-18 | Molnlycke Ab | A dressing and a method for the manufacture thereof |
EP0206692A2 (en) * | 1985-06-14 | 1986-12-30 | Ed. Geistlich Söhne Ag Für Chemische Industrie | Topically administrable pharmaceutical compositions |
EP0206692A3 (en) * | 1985-06-14 | 1988-07-27 | Ed. Geistlich Söhne Ag Für Chemische Industrie | Topically administrable pharmaceutical compositions |
EP0608497A1 (en) * | 1992-10-30 | 1994-08-03 | Sparta Surgical Corporation | Hypertonic saline dressing |
Also Published As
Publication number | Publication date |
---|---|
GB2035802B (en) | 1982-11-17 |
US4608044A (en) | 1986-08-26 |
DE2945420C2 ( ) | 1989-01-12 |
EP0015933A1 (en) | 1980-10-01 |
EP0015933B1 (en) | 1984-08-01 |
SE7803697L (sv) | 1979-10-04 |
SE425350B (sv) | 1982-09-27 |
ES479183A1 (es) | 1979-07-16 |
GB2035802A (en) | 1980-06-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4414202A (en) | Composition for treatment of wounds | |
Gilchrist et al. | Wound treatment with Sorbsan—an alginate fibre dressing | |
US4778679A (en) | Method and composition for treatment of wounds | |
US5271943A (en) | Wound gel compositions containing sodium chloride and method of using them | |
JPH0614956B2 (ja) | 親水性バイオポリマーコポリエレクトロライト | |
US4608044A (en) | Compress for treatment of wounds | |
CN110935056A (zh) | 一种高吸湿性藻酸盐敷料制备方法 | |
Higgins et al. | Wound dressings and topical agents | |
AU612387B2 (en) | Pharmaceutical compositions promoting the wound healing and process for preparing same | |
RU2180856C1 (ru) | Средство для лечения ран | |
EP0034504B1 (en) | Combinations for the treatment of wounds | |
Maklebust | Using wound care products to promote a healing environment | |
US20180338867A1 (en) | Resorbable preparation for medical applications, and characteristic uses for said preparation | |
RU88961U1 (ru) | Перевязочный материал | |
JPH04226656A (ja) | 創傷の処置のための調製品における多糖類の利用 | |
MORANI | Trypsin therapy in the management of chronic surface ulcers | |
Williams | Tegagen alginate dressing for moderate to heavily exuding wounds | |
Dunn | Local wound care in the diabetic | |
RU2008005C1 (ru) | Способ лечения ран | |
Forrest | The treatment of pressure sores | |
Curtis et al. | New technique for local treatment of burns | |
SU1711896A1 (ru) | Способ лечени длительно незаживающих ран | |
Ruke et al. | New Modalities and Challenges in Diabetic Foot Management | |
Byrne | Wound Management and Bandaging | |
Morgan | Chlorophyll Therapy: A Review of 114 Cases |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Designated state(s): DE GB US |
|
AL | Designated countries for regional patents |
Designated state(s): FR |
|
RET | De translation (de og part 6b) |
Ref country code: DE Ref document number: 2945420 Date of ref document: 19801211 Format of ref document f/p: P |